About us - Newsroom - Media releases

Media releases

View 10 | 50 | 100 entries/page
Showing 1 - 8 of 8

The EU-funded project CARAT offers fellowships for a training course on CAR T cell manufacturing

The EU project CARAT has taken on the mission to deliver new tools and technologies to enable the wide use of novel personalized cancer treatment options. In 2017, CARAT will grant five scientists with a fellowship that gives them the opportunity to participate in a unique training.


January 24, 2017

Reliable and reproducible flow cytometry results

Miltenyi Biotec introduces the largest portfolio of recombinant antibodies optimized for flow cytometry – REAfinity™ Antibodies


December 8, 2016

The course schedule has arrived! MACS® Academy is starting its new program

Once again, the MACS® Academy is offering a comprehensive course program at its locations in Bergisch Gladbach, Germany and San Diego, USA, in 2017 - miltenyibiotec.com/macsacademy.
November 22, 2016

Miltenyi Biotec acquires exclusive rights for the distribution and development of the viral transduction enhancer Vectofusin-1® from Genethon

Genethon, a leader in the field of gene therapy treatments for rare diseases, and Miltenyi Biotec, a global front-runner in cell processing and related technologies in cell therapy, have announced the execution of an exclusive license to the patents and trademarks for the development and commercialization of Vectofusin-1® by Miltenyi Biotec.
September 29, 2016

CE marked MACS® IVD Antibodies by Miltenyi Biotec – Compliant with IVDD and produced according to ISO 13485

Miltenyi Biotec has expanded its assortment of antibodies with a series of CE marked in vitro-diagnostic medical devices – MACS® IVD Antibodies. They can be used in both clinical flow cytometry and in the quality control of cellular products for translational research.
September 19, 2016

MACSxpress Treg Isolation Kit, human: Quick and efficient isolation of regulatory T cells

MACSxpress Treg Isolation Kit, human from Miltenyi Biotec facilitates both the fast and efficient isolation of regulatory T (Treg) cells from a maximum of 30 ml of fresh, anticoagulated whole blood
July 21, 2016

New: The MACSPlex Exosome Kit, human from Miltenyi Biotec

Miltenyi Biotec has extended its portfolio with the MACSPlex Exosome Kit, human. The fast and efficient process enables the characterization of 37 exosome surface markers in a single experiment.
June 21, 2016

New: Viobility™ Fixable Dyes from Miltenyi Biotec

The new Viobility™ Fixable Dyes from Miltenyi Biotec allow the swift discrimination between live and apoptotic or dead cells by flow cytometry. The three dyes react with the primary amino groups of proteins. Optimized for various fluorescence channels, they are available from now on.
April 29, 2016

View 10 | 50 | 100 entries/page
Showing 1 - 8 of 8

Customer login

Go

Forgot password?
Register for account

0 Shopping cart

Contact

Miltenyi Biotec Inc.
Phone: +1 800 FOR MACS
Fax:+1 877 591 1060
macs@miltenyibiotec.com
Contact overview

Product finder

Antibody panel builder

Toolbox

Loading...
Media contact

Media contact

Change country

Please select your country to continue